RSS-Feed abonnieren

DOI: 10.1055/s-0045-1802961
Jitter and muscle fiber conduction velocity in long COVID fatigue
Funding Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP), Brazil, supported this work (grant number 2022/02291-1 to JAK).

Abstract
Background Long coronavirus disease (long COVID, LC) is defined as the continuation or development of new symptoms 3 months after the acute stage of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. In LC, the rate of fatigue/postexertional malaise (F-PEM) has been described to be as high as 70%, regardless of age or severity of the acute symptoms.
Objective To evaluate the neuromuscular junction (NMJ) function and the isolated muscle fiber conduction velocity (MFCV) in situ in LC cases and controls.
Methods We studied 37 subjects without SARS-CoV-2 (controls) and 32 cases of SARS-CoV-2 infection, half with LC symptoms (LC-yes) and half without them (LC-no). Single-fiber electromyography (jitter measured with a concentric electrode), MFCV, the fast-to-slow MFCV ratio (F/S ratio), and the motor unit potentials (MUPs) were taken in the tibialis anterior muscle.
Results At least 1 jitter parameter was abnormal in 1/37 controls, in 1/16 LC-no patients, and in 2/16 LC-yes patients, without significant differences among them. None of the subjects with abnormal jitter presented fluctuation symptoms or positive acetylcholine-receptor antibody. The MFCV and F/S ratios did not show abnormalities in any of the participants. The MUPs did not show myopathic or neurogenic abnormality in needle electromyography. The most frequent symptom in LC was F-PEM, which occurred in all LC-yes patients and was significantly different from the other groups.
Conclusion Fatigue/postexertional malaise was found in all cases of LC, and the electrophysiological findings did not indicate the muscle fiber or the NMJ as a relevant factor in this condition.
Keywords
SARS-CoV-2 - Post-Acute COVID-19 Syndrome - Fatigue - Single-Fiber Electromyography - Muscle Fiber Conduction VelocityAuthors' Contributions
JAK: conceptualization and/or design of the work, data acquisition (neurophysiological tests), analysis and/or interpretation of data, writing – original draft, and writing –review and editing; CRG: data acquisition (interview), analysis and/or interpretation of data, writing – original draft, and writing –review and editing; LARY: participant selection and analysis and/or interpretation of data. All authors approved the final version of the manuscript and agree to be responsible for all aspects of the work.
Data Availability Statement
The data supporting the present study's findings are openly available upon reasonable request in the Data Center of Faculdade de Medicina de São José do Rio Preto, state of São Paulo, Brazil.
Editor-in-Chief: Hélio A. G. Teive.
Associate Editor: Carlos Otto Heise.
Publikationsverlauf
Eingereicht: 29. August 2024
Angenommen: 13. Oktober 2024
Artikel online veröffentlicht:
24. Februar 2025
© 2025. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution 4.0 International License, permitting copying and reproduction so long as the original work is given appropriate credit (https://creativecommons.org/licenses/by/4.0/)
Thieme Revinter Publicações Ltda.
Rua Rego Freitas, 175, loja 1, República, São Paulo, SP, CEP 01220-010, Brazil
João Aris Kouyoumdjian, Leticia Akemi Rama Yamamoto, Carla Renata Graca. Jitter and muscle fiber conduction velocity in long COVID fatigue. Arq Neuropsiquiatr 2025; 83: s00451802961.
DOI: 10.1055/s-0045-1802961
-
References
- 1 Zhu N, Zhang D, Wang W. et al; China Novel Coronavirus Investigating and Research Team. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med 2020; 382 (08) 727-733
- 2 World Health Organization. Coronavirus (COVID-19) Dashboard, site https://covid19.who.int/, searched on June 17, 2024.
- 3 Davis HE, McCorkell L, Vogel JM, Topol EJ. Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol 2023; 21 (03) 133-146
- 4 World Health Organization - Post COVID-19 condition (Long COVID) - https://www.who.int/europe/news-room/fact-sheets/item/post-covid-19-condition# , December 2022.
- 5 Yong SJ. Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments. Infect Dis (Lond) 2021; 53 (10) 737-754
- 6 Hejbøl EK, Harbo T, Agergaard J. et al. Myopathy as a cause of fatigue in long-term post-COVID-19 symptoms: Evidence of skeletal muscle histopathology. Eur J Neurol 2022; 29 (09) 2832-2841
- 7 Mahmud R, Rahman MM, Rassel MA. et al. Post-COVID-19 syndrome among symptomatic COVID-19 patients: A prospective cohort study in a tertiary care center of Bangladesh. PLoS One 2021; 16 (04) e0249644
- 8 Sanchez-Ramirez DC, Normand K, Zhaoyun Y, Torres-Castro R. Long-Term Impact of COVID-19: A Systematic Review of the Literature and Meta-Analysis. Biomedicines 2021; 9 (08) 900
- 9 Lopez-Leon S, Wegman-Ostrosky T, Perelman C. et al. More than 50 long-term effects of COVID-19: a systematic review and meta-analysis. Sci Rep 2021; 11 (01) 16144
- 10 Baker AME, Maffitt NJ, Del Vecchio A. et al. Neural dysregulation in post-COVID fatigue. Brain Commun 2023; 5 (03) fcad122
- 11 Huang C, Huang L, Wang Y. et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet 2021; 397 (10270): 220-232
- 12 Stålberg EV, Trontelj JV, Sanders DB. Single Fiber EMG. 3rd ed.. Fiskebäckskil, Sweden: Edshagen Publishing House; 2010
- 13 Stålberg E. Propagation velocity in human muscle fibers in situ. Acta Physiol Scand Suppl 1966; 287: 1-112
- 14 Kouyoumdjian JA, Graca CR. Concentric needle jitter: Reference values in stimulated Tibialis Anterior muscle. Front Neurol 2022; 13: 957174
- 15 Sanders DB, Arimura K, Cui L. et al. Guidelines for single fiber EMG. Clin Neurophysiol 2019; 130 (08) 1417-1439
- 16 Kouyoumdjian JA, Graca CR. Muscle fiber conduction velocity in situ revisited: A new approach to an ancient technique. Front Neurol 2023; 14: 1118510
- 17 Sanders DB, Kouyoumdjian JA, Stålberg EV. Single fiber electromyography and measuring jitter with concentric needle electrodes. Muscle Nerve 2022; 66 (02) 118-130
- 18 Ceban F, Ling S, Lui LMW. et al. Fatigue and cognitive impairment in Post-COVID-19 Syndrome: A systematic review and meta-analysis. Brain Behav Immun 2022; 101: 93-135
- 19 Halpin SJ, McIvor C, Whyatt G. et al. Postdischarge symptoms and rehabilitation needs in survivors of COVID-19 infection: A cross-sectional evaluation. J Med Virol 2021; 93 (02) 1013-1022
- 20 Arnold DT, Hamilton FW, Milne A. et al. Patient outcomes after hospitalisation with COVID-19 and implications for follow-up: results from a prospective UK cohort. Thorax 2021; 76 (04) 399-401
- 21 Al-Aly Z, Bowe B, Xie Y. Long COVID after breakthrough SARS-CoV-2 infection. Nat Med 2022; 28 (07) 1461-1467
- 22 Blomberg B, Mohn KG, Brokstad KA. et al; Bergen COVID-19 Research Group. Long COVID in a prospective cohort of home-isolated patients. Nat Med 2021; 27 (09) 1607-1613
- 23 Alkodaymi MS, Omrani OA, Fawzy NA. et al. Prevalence of post-acute COVID-19 syndrome symptoms at different follow-up periods: a systematic review and meta-analysis. Clin Microbiol Infect 2022; 28 (05) 657-666
- 24 Salamanna F, Veronesi F, Martini L, Landini MP, Fini M. Post-COVID-19 Syndrome: The Persistent Symptoms at the Post-viral Stage of the Disease. A Systematic Review of the Current Data. Front Med (Lausanne) 2021; 8: 653516
- 25 Rochmawati E, Iskandar AC, Kamilah F. Persistent symptoms among post-COVID-19 survivors: A systematic review and meta-analysis. J Clin Nurs 2022; •••
- 26 Angarita-Fonseca A, Torres-Castro R, Benavides-Cordoba V. et al. Exploring long COVID condition in Latin America: Its impact on patients' activities and associated healthcare use. Front Med (Lausanne) 2023; 10: 1168628
- 27 Buttery S, Philip KEJ, Williams P. et al. Patient symptoms and experience following COVID-19: results from a UK-wide survey. BMJ Open Respir Res 2021; 8 (01) e001075
- 28 Davis HE, Assaf GS, McCorkell L. et al. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine 2021; 38: 101019
- 29 Raveendran AV, Jayadevan R, Sashidharan S. Long COVID: An overview. Diabetes Metab Syndr 2021; 15 (03) 869-875
- 30 Nalbandian A, Sehgal K, Gupta A. et al. Post-acute COVID-19 syndrome. Nat Med 2021; 27 (04) 601-615
- 31 Townsend L, Dyer AH, Jones K. et al. Persistent fatigue following SARS-CoV-2 infection is common and independent of severity of initial infection. PLoS One 2020; 15 (11) e0240784
- 32 Abrams RMC, Zhou L, Shin SC. Persistent post-COVID-19 neuromuscular symptoms. Muscle Nerve 2023; 68 (04) 350-355
- 33 Suh J, Amato AA. Neuromuscular complications of coronavirus disease-19. Curr Opin Neurol 2021; 34 (05) 669-674
- 34 Carfì A, Bernabei R, Landi F. Gemelli Against COVID-19 Post-Acute Care Study Group. Persistent Symptoms in Patients After Acute COVID-19. JAMA 2020; 324 (06) 603-605
- 35 Scordo KA, Richmond MM, Munro N. Post-COVID-19 Syndrome: Theoretical Basis, Identification, and Management. AACN Adv Crit Care 2021; 32 (02) 188-194
- 36 Elanwar R, Hussein M, Magdy R. et al. Physical and Mental Fatigue in Subjects Recovered from COVID-19 Infection: A Case-Control Study. Neuropsychiatr Dis Treat 2021; 17: 2063-2071
- 37 Adams and Victor's Principles of Neurology. Ropper AH, Samuels MA, Klein JP, Prasad S. eds. 20th ed.. New York: McGraw Hill LLC; 2023
- 38 Tankisi H, Versace V, Kuppuswamy A, Cole J. The role of clinical neurophysiology in the definition and assessment of fatigue and fatigability. Clin Neurophysiol Pract 2023; 9: 39-50
- 39 Agergaard J, Leth S, Pedersen TH. et al. Myopathic changes in patients with long-term fatigue after COVID-19. Clin Neurophysiol 2021; 132 (08) 1974-1981
- 40 Agergaard J, Yamin Ali Khan B, Engell-Sørensen T. et al; MULTICOV Consortium. Myopathy as a cause of Long COVID fatigue: Evidence from quantitative and single fiber EMG and muscle histopathology. Clin Neurophysiol 2023; 148: 65-75